Brief: Pharmaust Seeks Trading Halt
17/08/2023 11:18
Aug 17 (Reuters) - Pharmaust Ltd PAA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT OF NEUROFILAMENT
LIGHT
CHAIN RESULTS FROM MOTOR NEURONE DISEASE PHASE 1/2 CLINICAL
TRIAL
Source text for Eikon: ID:nASXbZ9zGz
Further company coverage: PAA.AX
(Reporting by Shivangi Lahiri)
((Shivangi.Lahiri@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility